Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1)
European Journal of Cancer2015Vol. 53, pp. 42–50
Citations Over TimeTop 10% of 2015 papers
Sook Ryun Park, Young Soo Park, Min‐Hee Ryu, Baek‐Yeol Ryoo, Chang Gok Woo, Hwoon‐Yong Jung, Jeong Hoon Lee, Gin Hyug Lee, Yoon‐Koo Kang
Related Papers
- → A Validation Study of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Digital Imaging Analysis and its Correlation with Human Epidermal Growth Factor Receptor 2 Fluorescence In situ Hybridization Results in Breast Carcinoma(2020)31 cited
- → Normalization of pH level and gastric mucosa after eradication of H. pylori in the remnant stomach(2008)17 cited
- Diagnose and Treatment of Stomach Malignant Stromal Tumors(2005)
- Expression of HCCR, pERK, pELK1 in gastric cancer and its correlations(2014)
- → Necessity of In Situ Hybridization Test of Human Epidermal Growth Factor Receptor 2 (HER2) Status in Breast Cancer Patients with Equivocal HER2 Immunohistochemistry Results(2018)